Bright Minds Biosciences announced the formation of its Scientific Advisory Board (SAB). The Company named the following inaugural members: Herbert Y. Meltzer, MD, Northwestern University; Karl Deisseroth, MD, PhD, Stanford University; Robert C. Malenka, MD, PhD, Stanford University; Michael P. Bogenschutz, MD, NYU Langone Health; and Peter Hendricks, PhD, University of Alabama.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 CAD | -6.92% | -9.76% | -30.19% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.19% | 4.8M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- DRUG Stock
- News Bright Minds Biosciences Inc.
- Bright Minds Biosciences Establishes Scientific Advisory Board